RE:RE:RE:Dying?My apologies if that was a sincere question. There is no way Theralase is dying a slow death. The company just raised 17 million $ which is enough to cover the entire phase 2 - so whatever ups and downs the sp experiences the company will be around for at least several years attempting to prove it's value. Everybody who has been here for a while knows that Theralase has a safe, convenient, highly efficacious treatment for bladder cancer which has been underrated by the market for a whole host of reasons. The only way Theralase could die would be if the FDA nixed the phase2 and then it would be a sudden death not a slow death. Needless to say, no-one expects that to happen. Once the trial starts in the US we can expect a significant increase in the number of treatments and as 2020 progresses, a significant uptick in the sp.
Maddmartigan wrote: How is asking a question ill informed?